Results 141 to 150 of about 48,841 (237)
Placebo arms show substantial improvement in cholestatic pruritus, with up to 30% response rate. Estimates differed across outcome instruments, highlighting the importance of endpoint selection and realistic placebo assumptions in future trial design.
Igor Boechat Silveira +8 more
wiley +1 more source
Liver Organoids: From Disease Modelling to Regenerative Medicine
Liver organoids provide a versatile platform for disease modelling and drug discovery, leveraging stem cells and engineering techniques. They bridge research and clinical applications, offering significant potential for advancing precision medicine and regenerative therapies for liver diseases.
Tiepeng Wang +5 more
wiley +1 more source
Rare Variants in PFIC‐Related Genes Among Adults With Intrahepatic Cholestasis
ABSTRACT Aim Biallelic pathogenic variants in progressive familial intrahepatic cholestasis (PFIC)‐related genes cause severe pediatric cholestasis. However, the clinical significance of heterozygous variants in adult intrahepatic cholestasis remains unclear.
Shunji Hirose +9 more
wiley +1 more source
Pemafibrate Improves Cholestatic Markers Regardless of the Presence of Primary Biliary Cholangitis
Pemafibrate improves liver function markers related to bile flow in primary biliary cholangitis (PBC), but whether this effect is disease‐specific remains unclear. In this study, pemafibrate reduced these markers in patients with and without PBC, suggesting broader effects on bile flow beyond PBC.
Ryohei Tanigawa +5 more
wiley +1 more source
ABSTRACT Background and Aim Alcohol‐associated liver disease frequently presents late as decompensated cirrhosis, representing a missed opportunity for intervention. Extrahepatic alcohol‐related presentations requiring acute care, such as alcohol‐associated pancreatitis and alcohol withdrawal syndrome, may identify heavy drinkers at varying risk for ...
Butros Fakhoury +5 more
wiley +1 more source
Primary sclerosing cholangitis [PDF]
P, Angulo, K D, Lindor
openaire +2 more sources
Sclerosing cholangitis from microscopic polyarteritis: an 8-year follow-up case report
Sclerosing cholangitis from microscopic polyarteritis: an 8-year follow-up case ...
J Co (13409466) +3 more
core
Paradoxical hepcidin-iron dysregulation in primary sclerosing cholangitis. [PDF]
Kordac P +9 more
europepmc +1 more source
Five critical blind spots limiting translational progress in primary sclerosing cholangitis. [PDF]
Cornillet M.
europepmc +1 more source
CCL24 Blockade with Nebokitug Modulates Inflammation and Fibrosis Signatures in Primary Sclerosing Cholangitis. [PDF]
Aricha R, Snir T, Lawler J, Mor A.
europepmc +1 more source

